Skip to main content
Equibles

MORGAN STANLEY

Position in GLSI — Greenwich LifeSciences, Inc.

CIK 895421 NEW YORK, NY
Back to GLSI Full portfolio

Position in GLSI

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$1,019,263
+$302,822 QoQ
Shares Held
43,447
+45.7% QoQ
Ownership
0.296%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#9
of 57 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority Sole 77% Shared 0% None 23%

Common Shares in GLSI Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MORGAN STANLEY holds $16,838,649,954 across 523 Biotechnology names. GLSI ranks #250 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RPRX
Royalty Pharma plc
 42,931,597 $2,407,174,637
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,242,139 $1,610,467,694
3 ROIV
Roivant Sciences Ltd.
 42,592,905 $1,507,362,901
4 REGN
Regeneron Pharmaceuticals, Inc.
 1,397,712 $871,529,332
5 MRNA
Moderna, Inc.
 9,538,094 $667,952,718
6 ARGX
Argenx SE
 643,123 $596,670,219
7 TECH
BIO-TECHNE Corp
 6,374,717 $450,373,747
8 INCY
Incyte Corp
 2,948,364 $334,226,536

All Filings in GLSI

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,019,263 43,447
2026-03-31 $716,441 29,827
2025-12-31 $554,220 26,379
2025-09-30 $86,771 8,721
2025-06-30 $106,716 11,766
2025-03-31 $91,076 9,547
2024-12-31 $154,680 13,774
2024-09-30 $244,733 17,031
2024-06-30 $121,733 7,053
2024-03-31 $124,224 6,230
2023-12-31 $2,945 280
2023-09-30 $2,475 280
2023-06-30 $7,300 757
2023-03-31 $98,223 7,123
2022-12-31 $132,588 8,723
2022-09-30 $320,637 35,235
2022-06-30 $619,916 73,190
2022-03-31 $425,890 21,707
2021-12-31 $879,721 36,158
2021-09-30 $27,229 697
2021-06-30 $377,540 8,401
2021-03-31 $157,563 4,622
2020-12-31 $138,694 3,803